Learn and benchmark with attendees from the main cell, gene and immunotherapy communities.
Optimise your process, manufacturing capabilities and analytical strategies:
How do you deal with the challenge of CMO selection, process transfer, and demonstration of comparability?
What are the requirements for the commercial manufacturing process?
What other steps must be taken in order to launch large scale manufacturing?
What is best practise for defining the efficacy of your product?
How do you correlate raw material attributes to your cells?
What is best practise for assessing critical raw materials?
Ensure stringent cold chain and process automation strategies:
How do you develop a stringent, commercially viable manufacturing strategy?
How do you bring bioprocessing technologies to these therapies to allow them to be made for the masses?
What is best practise for keeping costs down in scale-out systems?
How do you design facilities to make them financially feasible?
What is best practise when working with automated systems for bioreactors?
What are the major questions and issues surrounding cryopreservation?
Learn how to accelerate preclinical studies and push products into the clinic:
Which new applications are showing the biggest promise for the clinic?
What is needed from preclinical studies so a product can move smoothly into the clinic?
How do you apply risk based approaches to reduce the amount of data required?
How can the results from preclinical animal models be used to convince investors that your product is worthwhile?
What is the best way to set CQA's early on in your process?
How have companies secured funding for preclinical studies?
Optimise your process, manufacturing capabilities and analytical strategies:
How do you deal with the challenge of CMO selection, process transfer, and demonstration of comparability?
What are the requirements for the commercial manufacturing process?
What other steps must be taken in order to launch large scale manufacturing?
What is best practise for defining the efficacy of your product?
How do you correlate raw material attributes to your cells?
What is best practise for assessing critical raw materials?
Ensure stringent cold chain and process automation strategies:
How do you develop a stringent, commercially viable manufacturing strategy?
How do you bring bioprocessing technologies to these therapies to allow them to be made for the masses?
What is best practise for keeping costs down in scale-out systems?
How do you design facilities to make them financially feasible?
What is best practise when working with automated systems for bioreactors?
What are the major questions and issues surrounding cryopreservation?
Learn how to accelerate preclinical studies and push products into the clinic:
Which new applications are showing the biggest promise for the clinic?
What is needed from preclinical studies so a product can move smoothly into the clinic?
How do you apply risk based approaches to reduce the amount of data required?
How can the results from preclinical animal models be used to convince investors that your product is worthwhile?
What is the best way to set CQA's early on in your process?
How have companies secured funding for preclinical studies?
